Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Notch and Memory: More Trouble for γ-Secretase Inhibition?
14 June 2004. Katsutoshi Furukawa and colleagues at the National Institute on Aging, Baltimore, report in the June 9 early online PNAS that Notch signaling is required for LTP in adult mice. This finding is relevant to AD researchers because inhibiting γ-secretase, the protein complex responsible for generating the Aβ peptide, could be an attractive therapeutic strategy for Alzheimer’s disease if it weren’t for the inconvenient fact that γ-secretase also helps process the signal transduction molecule Notch. Clearly indispensable in development, the functions of Notch in adults remain poorly defined. A role in thymocyte maturation is known and tied to the toxicity of classic γ-secretase inhibitors (see ARF related news story). What's more, recent experiments have shown that ablating the catalytic core of γ-secretase leads to memory and learning defects in adult mice; these include the dampening of long-term potentiation (LTP), a phenomenon that is integral to the learning process (see ARF related news story). Furukawa’s current work extends this last observation.

First author Yue Wang and colleagues made their discovery while characterizing Notch antisense (NAS) mice. Expressing antisense Notch RNA, these animals are known to have their Notch expression reduced by 50 to 70 percent in hematopoietic cells. When the scientists examined hippocampal cells, they found similar reductions in protein levels. To trace the consequences of this loss, Wang and colleagues measured high frequency stimulation (HFS)-induced activation of NF-kB, a known downstream target in the Notch signaling pathway. Mobility shift assays visualize activation of this transcription factor, and the scientists found that while HFS causes robust mobility shifts of samples from normal mice, NF-kB activation in NAS mice undergoing the same stimulation was negligible.

Does this have physiological consequences? To address this issue, Wang and colleagues compared neurotransmission in hippocampal slices. Basal transmission was similar in wild-type and NAS hippocampal tissue; however, HFS-stimulated increases in postsynaptic potentials, a common measure of LTP, nearly doubled in normal mice but were absent in NAS mice. In addition, low frequency stimulation used to induce the opposite of LTP, long-term depression (LTD), caused much greater reduction in postsynaptic potentials in NAS mice. Taken together, these results suggest that Notch signaling participates in the regulation of LTP and LTD and, by extension, in learning and memory.

As for the potential use of γ-secretase inhibitors for AD, the authors join a growing chorus of scientists when they caution that “efforts to develop γ-secretase inhibitors as therapeutic agents for Alzheimer’s disease, based on their ability to reduce generation of amyloid-β peptide from amyloid precursor protein, may be hampered by the simultaneous inhibition of Notch 1 cleavage.” It is worth noting, though, that some researchers hold out hope that new drugs can be developed that selectively inhibit the amyloid cleavage activity of γ-secretase while leaving Notch cleavage intact (see ARF related news story).—Tom Fagan.

Reference:
Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP, Furukawa K. Involvement of Notch signaling in hippocampal synaptic plasticity. PNAS June 2004. Early Edition. Abstract

 
Comments on News and Primary Papers
  Comment by:  Carlos A. Saura
Submitted 22 June 2004  |  Permalink Posted 22 June 2004

Notch signaling plays a crucial role on cell fate specification during neuronal development in C. elegans, Drosophila and vertebrates. In the adult brain, however, the role of Notch signaling on neuronal morphology and function is largely unknown. Now, Wang et al. used Notch-1 antisense (NAS) transgenic mice expressing reduced levels of Notch-1 to demonstrate that Notch signaling is required for synaptic plasticity in the hippocampus, a brain region classically implicated in the acquisition of new memories. These authors found reduced maintenance of LTP and enhanced LTD in NAS-transgenic mice. Impaired LTP in hippocampal slices from NAS-transgenic mice was associated with reduced CBF1 activation, whereas incubation with the Notch ligand Jagged-1 increased Notch activity and LTP.

This data linking Notch signaling and synaptic plasticity, together with recent findings from Alcino Silva’s lab (Costa et al., 2003; also see ARF related news...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad